Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 2 James C. Thomas, MPH, PhD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):489-491. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311. In the Literature Apr 2004 Physicians as Citizens Philip A. Perry, MSJ Physicians should take part in public health advocacy to improve health care for all patients. Virtual Mentor. 2004;6(4):171-173. doi: 10.1001/virtualmentor.2004.6.4.jdsc1-0404. Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512. Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12
Case and Commentary Nov 2003 Please Don't Say Anything: Partner Notification and the Patient-Physician Relationship, Commentary 2 James C. Thomas, MPH, PhD When a public health risk exists, a physician's obligations to warn those in potential danger overrides rules of patient confidentiality. Virtual Mentor. 2003;5(11):489-491. doi: 10.1001/virtualmentor.2003.5.11.ccas2-0311.
In the Literature Apr 2004 Physicians as Citizens Philip A. Perry, MSJ Physicians should take part in public health advocacy to improve health care for all patients. Virtual Mentor. 2004;6(4):171-173. doi: 10.1001/virtualmentor.2004.6.4.jdsc1-0404.
Case and Commentary Jul 2024 How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD? Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary. AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.
Podcast Jul 2024 Author Interview: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?” Dr Katherin M. Duthie joins Ethics Talk to discuss her article, coauthored with Dr Kathryn A. Dong: “How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?”